COMMUNICATION: Pilar García, medical director of the Jérôme Lejeune Foundation in Spain

(Information sent by the signing company).

COMMUNICATION: Pilar García, medical director of the Jérôme Lejeune Foundation in Spain

(Information sent by the signing company)

The Jérôme Lejeune Foundation, whose purpose is to provide comprehensive and scientifically based care for people with genetic disabilities, incorporates Dr. Pilar García as medical director. Among her functions is the medical direction of the first care center in Spain that the Foundation will open at the end of 2022 in Madrid. It will have 11 medical specialties and its challenge is to serve 4,000 patients a year, when it is fully operational

A long international and national career in child neurodevelopment. Graduated in Medicine and Surgery from the University of Granada. She holds a doctorate in Medicine and Surgery from the University of Cádiz. She is a MIR specialist in Paediatrics and her specific areas through the opposition for Internal Resident Physician, at the General Hospital of Jerez de la Frontera (Cádiz). She has developed her general pediatric care activity both in the public and private spheres, both in primary and hospital care. She is a pediatrician of the basic primary care teams in Andalusia by opposition. Her specialization is child neurodevelopment. She has worked in this area in the UK for the National Health System (NHS), in two hospitals: St. James' University Hospital (Leeds Foundation Trust), and Leighton Hospital (Mid Cheshire Hospitals). In Andalusia, she actively participated in the implementation of the care activity that arose from the Early Care Law. She has subsequently been part of the Neuropaediatrics Area of ​​the Navarra University Clinic in Madrid. "We are proud to have Pilar because her professional and human quality will help us provide medical and specialized care for this group. In Spain it is estimated that there are 35,000 people with Trisomy 21, although in official records only 16,500, and this without counting other lesser-known disabilities such as Williams, Fragile X, Phelan-McDermit, S. Kabuki or Smith Magenis", explains Pablo Siegrist, general director of the Jérôme Lejeune Foundation in Spain. The Jérôme Lejeune Medical Institute in Paris: more than 12,000 people treated since 1997 The Medical Center in Madrid will replicate the work of the Lejeune Institute in Paris, the first European center specialized in the comprehensive treatment of genetic diseases of intelligence with a unique philosophy inherited from Dr. Lejeune. It is based on: Time dedicated to patients, comprehensive care throughout the patient's life (a single medical record guarantees the continuity of information on each patient regardless of the professional treating them: pediatrician, internist or geriatrician) and the relationship between clinical observation and research. About the Jérôme Lejeune Foundation The Foundation began its work in France in 1995 after the death of Dr. Jérôme Lejeune, considered the father of modern genetics for discovering, in 1958, trisomy 21, the genetic cause of Down's Syndrome. Director of the Center National de la Recherche Scientifique, first holder of the chair of genetics at the Faculty of Medicine of Paris and head of the service of the same specialty at the Necker-Enfants Malades hospital, he dedicated his life to caring for and treating children and young people with a genetic disability, while continuing to investigate to understand and seek ways to improve their quality of life. The purpose of his Foundation is: to provide comprehensive and scientifically based care for people with intellectual disabilities of genetic origin. To do this, they work on three pillars: promoting research, generating specialized medical care and defending human dignity. Between 4 and 5 million euros per year dedicated to research, a biobank in Paris with more than 20,000 samples and 3 medical centers - Paris, Nantes and Córdoba (Argentina) - through which more than 12,000 patients pass annually, are its key figures. In 2008, the Lejeune Foundation created the "Jérôme Lejeune" International Chair in Bioethics under the direction of Dr. Mónica López Barahona. This chair has developed training initiatives and the publication of popular science works in the field of Bioethics such as the "Bioethics Manual for Young People", the "Bioethics Manual at the end of life" or the "Manual on Assisted Reproduction" , among others. About the Jérôme Lejeune Foundation in Spain The Foundation has been in Spain since 2015. This year the International Chair of Bioethics is integrated into the Foundation in Spain. Since its inception, more than 2.5 million euros have been allocated to clinical and basic research. In the field of training, the University Master's Degree in Bioethics stands out, in collaboration with the Francisco de Vitoria University. At the end of 2022 they will open their first medical center in Spain, in Madrid, with the intention of providing comprehensive care annually to more than 4,000 people with intellectual disabilities of genetic origin.

ContactContact name: Quum CommunicationContact description: Quum CommunicationContact telephone number: 914426026

NEXT NEWS